# Author Interview: Professor Matthew Brown, 2026

Page: https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-matthew-brown-2026
Text version: https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-matthew-brown-2026.md
Podcast: [The IMID Forum](https://stenobird.com/podcast/the-imid-forum-981476)
Published: 2026-02-03T14:36:46+00:00
Episode link: https://soundcloud.com/imidforum/author-interview-professor-matthew-brown-2026
Audio file: https://feeds.soundcloud.com/stream/2259424706-imidforum-author-interview-professor-matthew-brown-2026.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-matthew-brown-2026
Duration seconds: 1109

## Resource

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Matthew Brown, the Chief Scientific Officer at Genomics England, as they discuss his recent paper ‘Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: Pooled results from Phase 2b/3 trials’.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-matthew-brown-2026/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-matthew-brown-2026.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.